MND in the Family and the Benefit Inside a Life Policy

Motor neurone disease has appeared in your family and you are trying to work out two things at once: whether it is hereditary, and what a life insurance policy would actually do about it. Take the first quickly, because it is reassuring. Most motor neurone disease is not inherited. The large majority of cases are sporadic — they arise in someone with no other affected relative — and only a minority run in families.

The second question is the more useful one, and it has a clearer answer than most people expect. If MND is the risk on your mind, the part of a life policy that matters most is not the headline sum assured but a feature built quietly into most term cover: the terminal illness benefit. It is designed to pay that sum assured while you are still alive, on diagnosis, rather than only on death. With a condition that is often diagnosed with a short prognosis, that is the feature most likely to be reached.

None of this is a promise that a particular claim will be paid. Terminal illness benefit turns on a specific definition, and the definitions differ between insurers. But it is the right place to point your attention, and this page explains why — what the wording tends to say, and how the family-history side sits on an application.

Is motor neurone disease hereditary?

For most families, no. The typical case of MND occurs in a person with no known family history of it, and having a single relative affected does not, by itself, mean a fault is running through the family. That is worth sitting with for a moment, because the fear that follows a diagnosis in a parent or sibling often runs ahead of the actual odds.

A minority of cases are familial. These usually follow an autosomal dominant pattern, meaning a child of an affected parent has a raised chance of inheriting the relevant fault, and several genes have now been identified. There is also a recognised overlap between MND and frontotemporal dementia, so a family history that includes both can be part of the picture a specialist considers. Where the pattern suggests an inherited cause — several affected relatives, younger ages at onset, or that overlap with frontotemporal dementia — NHS genetics services can assess the family and discuss whether testing is appropriate.

If you are trying to place your own risk against the background rate rather than the frightening headline, that instinct is the right one, and it is the same instinct that helps with other family histories, such as working out what a mother's stroke at 52 means for you. The NHS sets out the general picture of who develops MND and the small role inheritance plays in it, which is a calmer starting point than most of what a late-night search turns up.

Source: NHS, information on motor neurone disease causes and inheritance, nhs.uk.

The genetic side: what an insurer can and cannot ask

If a genetic test is done in your family and you have a predictive result — a result taken while you are well, before any symptoms — that result cannot be asked for on a UK life insurance application. The Code on Genetic Testing and Insurance keeps predictive results off the form, with a single exception for Huntington's disease above £500,000 of life cover, which does not touch MND.

Source: HM Government and the Association of British Insurers, Code on Genetic Testing and Insurance, published on gov.uk.

What is disclosable, if asked, is ordinary medical fact: symptoms you have had, investigations, a diagnosis, treatment. The gene result stays out; the clinical history does not. And because the £500,000 threshold sits above where most policies are written, the genetic exception rarely bites at all for an ordinary applicant — a point we set out in full in most life policies never reach the genetic testing threshold. For someone who is currently well but has MND in the family, the practical position is straightforward: apply as the well person you are, answer the family-history questions honestly, and the predictive result is not something the insurer gets to see.

The part of a policy that actually matters: terminal illness benefit

Here is the feature to understand. Most UK term life policies include, at no separate charge, a terminal illness benefit. It means that if you are diagnosed with a terminal illness during the policy term, and the prognosis meets the policy's definition — normally that you are not expected to live more than twelve months — the insurer can pay the sum assured then, rather than waiting until death.

This is the answer to the question people phrase as "does life insurance pay out on diagnosis". Ordinarily a life policy pays on death. The terminal illness benefit is the route by which it can pay earlier, and it exists precisely so that money is available when a family most needs to reorganise its life — to stop working to provide care, to clear a mortgage, to remove one source of pressure from a year that has more than enough of them.

One thing to be clear about, because it is often misunderstood: the terminal illness benefit brings the single payment forward. It does not add a second sum on top. If it pays on diagnosis, the policy has done its job and there is no further death benefit to come afterwards. You are receiving the same money sooner, not extra money.

Why this feature matters specifically for MND

Terminal illness benefit exists on most policies, but with many conditions it is rarely triggered, because they progress slowly or are caught and treated long before any twelve-month prognosis is reached. Motor neurone disease is different. It is frequently diagnosed with a poor prognosis, and the twelve-month definition can therefore be met in a way it seldom is with slower illnesses.

That is why, for a family whose worry is MND specifically, the terminal illness benefit is the part of the policy to weigh rather than an afterthought. It is the mechanism most likely to be reached, and it is the mechanism that gets money to the household during life rather than after it. None of that guarantees any individual claim — a claim still depends on the diagnosis, the prognosis and the policy definition all lining up — but it does mean the feature is doing real work here rather than sitting unused.

Read the wording, not the brochure

Because so much turns on the definition, the policy wording is the document that matters, and the differences between insurers are not cosmetic. The prognosis period is usually twelve months, but the exact test — how "terminal" is defined, what medical evidence is required, which specialist's opinion counts — varies. Two policies with the same sum assured can behave differently at the point of an MND diagnosis.

There is a further detail worth knowing. On many term policies the terminal illness benefit is not available in the last part of the term, because a twelve-month prognosis given near the end could fall outside the cover. Some products, and some whole-of-life arrangements, handle it differently again. None of this should put you off; it should tell you to have the wording checked before you assume how a claim would run. An FCA-authorised broker can compare the terminal illness definitions across insurers, which is exactly the sort of difference a comparison is for.

It also helps to know how a claim is actually assessed, so it does not feel like a black box. The insurer relies on medical evidence — usually from the specialists treating you — that the illness is terminal and that the expected prognosis falls inside the policy's period. It is not a self-declaration, and it is not a payment triggered simply by the word "terminal" appearing in a letter. That is another reason the definition matters: a policy that requires a firm twelve-month prognosis and a policy that reads slightly more generously can reach different answers on the same diagnosis, and neither is being unreasonable — they are applying the words you agreed to.

Getting cover with MND in the family

If you are well and MND runs in your family, you can apply for life insurance in the ordinary way. The application will ask about your age, whether you smoke, your height and weight, your own medical history, and your family history of certain conditions, which insurers are permitted to ask about at any level of cover. It will not ask for a predictive genetic result.

How a family history of MND is treated varies between insurers, which is one of the better reasons to compare rather than accept the first answer. When you are ready, you can get life insurance quotes and let a broker work through the family-history questions against your real circumstances. If a genetic test result exists in your family, the same protections that apply to MND apply to the inherited-cancer questions covered elsewhere in this cluster, such as two generations of breast cancer on one side of the family. And if you are thinking ahead about children, the question of whether an insurer can ever see a child's sequencing result is its own topic — see your newborn's genome was sequenced, so are they insurable.

Where else money can come from, and how the UK nations differ

Terminal illness benefit is not the only source of support a family might have. An employer's death in service scheme can pay a lump sum, though it is tied to the job and stops when the employment does; we look at what that actually amounts to for one household in what two years' pay buys a nurse's family. The point of understanding the terminal illness benefit is that it is money you control, arranged in advance, and reachable during life.

On the insurance side, the rules here are UK-wide: the Code on Genetic Testing and Insurance and the terminal illness features of policies apply the same way in England, Scotland, Wales and Northern Ireland. What varies by nation is the NHS genetics and neurology pathway — how families with a possible inherited cause are assessed and referred — so the clinical route your relatives follow may differ from one described for England, even though the insurance position does not.

Frequently asked questions

Is motor neurone disease hereditary?

Most cases are sporadic, with no other affected relative. A minority run in families, usually in an autosomal dominant pattern, with several genes now identified, and a family history of MND or of frontotemporal dementia raises the possibility. NHS genetics services assess families where the pattern suggests an inherited cause and discuss whether testing is appropriate.

What is terminal illness benefit?

It is a feature built into most UK term life policies that pays the sum assured early where you are diagnosed with a terminal illness and the prognosis is normally twelve months or less. It brings the payment forward rather than adding a separate amount on top of the death benefit. The exact definition and the medical evidence required vary between insurers.

Why does it matter for MND?

Because MND is often diagnosed with a poor prognosis, the built-in benefit can be reached during life in a way it rarely is with slower conditions. That gets money to the household when it is most needed. Definitions and prognosis periods differ between insurers, so the policy wording is the thing to read, not the brochure.